Regulatory Sports Medicine Organogenesis Announces Successful FDA Meeting and Plan to File BLA for ReNu® for Knee Osteoarthritis Pain byTim AllenDecember 15, 2025
Neuro Sports Medicine SPRI and Neuromuscular Dynamics Launch NIH-Funded Clinical Trial to Advance Non-Surgical Knee Osteoarthritis Treatment byTim AllenNovember 18, 2025
Recon Regulatory Robotics Zimmer Biomet Receives U.S. FDA Clearance for Enhanced Version of ROSA® Knee Robotic Technology byJosh SandbergNovember 14, 2025
Regulatory Pacira BioSciences Presents Updated Three-Year Data Demonstrating Sustained Efficacy and Safety of PCRX-201 Gene Therapy for Patients with Moderate-to-Severe Osteoarthritis of the Knee byJosh SandbergOctober 28, 2025
Financial Recon Knee Reconstruction Market Grew by $210 Million During 2024-2025; Set to Reach $5.09 Billion by 2032 – Technology and Patient Demands are Transforming Surgical Practice byJosh SandbergOctober 27, 2025
Extremities Pacira BioSciences to Present 3-Year Data Demonstrating Sustained Pain and Function Improvements in Knee Osteoarthritis with Investigational PCRX-201 Gene Therapy byJosh SandbergOctober 21, 2025
Biologics Regulatory Doron Therapeutics Announces First Patients Dosed in Phase 3 Study of MOTYS (PTP-001) for the Treatment of Osteoarthritis of the Knee byTim AllenOctober 17, 2025
Sports Medicine NEXTBIOMEDICAL Announces First Patient Enrolled in U.S. FDA Pivotal Trial of Nexsphere-F™ for Knee Osteoarthritis Pain byJosh SandbergOctober 13, 2025
